372 related articles for article (PubMed ID: 16985166)
1. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
[TBL] [Abstract][Full Text] [Related]
2. The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel.
Wan TC; Ge ZD; Tampo A; Mio Y; Bienengraeber MW; Tracey WR; Gross GJ; Kwok WM; Auchampach JA
J Pharmacol Exp Ther; 2008 Jan; 324(1):234-43. PubMed ID: 17906066
[TBL] [Abstract][Full Text] [Related]
3. A(3) adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells.
Ge ZD; van der Hoeven D; Maas JE; Wan TC; Auchampach JA
J Mol Cell Cardiol; 2010 Aug; 49(2):280-6. PubMed ID: 20132822
[TBL] [Abstract][Full Text] [Related]
4. The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors.
Tian Y; Marshall M; French BA; Linden J; Yang Z
Basic Res Cardiol; 2015 Mar; 110(2):16. PubMed ID: 25711314
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits.
Auchampach JA; Rizvi A; Qiu Y; Tang XL; Maldonado C; Teschner S; Bolli R
Circ Res; 1997 Jun; 80(6):800-9. PubMed ID: 9168782
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
Mlejnek P; Dolezel P; Kosztyu P
J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
[TBL] [Abstract][Full Text] [Related]
7. A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs.
Auchampach JA; Ge ZD; Wan TC; Moore J; Gross GJ
Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H607-13. PubMed ID: 12689858
[TBL] [Abstract][Full Text] [Related]
8. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
[TBL] [Abstract][Full Text] [Related]
9. A role for histamine in cytokine modulation by the adenosine A(3) receptor agonist, 2-Cl-IB-MECA.
Smith SR; Denhardt G; Terminelli C
Eur J Pharmacol; 2002 Dec; 457(1):57-69. PubMed ID: 12460644
[TBL] [Abstract][Full Text] [Related]
10. Caspase inhibition via A3 adenosine receptors: a new cardioprotective mechanism against myocardial infarction.
Hussain A; Gharanei AM; Nagra AS; Maddock HL
Cardiovasc Drugs Ther; 2014 Feb; 28(1):19-32. PubMed ID: 24220799
[TBL] [Abstract][Full Text] [Related]
11. Activation of adenosine A3 receptors reduces ischemic brain injury in rodents.
Chen GJ; Harvey BK; Shen H; Chou J; Victor A; Wang Y
J Neurosci Res; 2006 Dec; 84(8):1848-55. PubMed ID: 17016854
[TBL] [Abstract][Full Text] [Related]
12. Role of adenosine receptor activation in antioxidant enzyme regulation during ischemia-reperfusion in the isolated rat heart.
Hochhauser E; Kaminski O; Shalom H; Leshem D; Shneyvays V; Shainberg A; Vidne BA
Antioxid Redox Signal; 2004 Apr; 6(2):335-44. PubMed ID: 15025935
[TBL] [Abstract][Full Text] [Related]
13. IB-MECA and cardioprotection.
Xu Z; Jang Y; Mueller RA; Norfleet EA
Cardiovasc Drug Rev; 2006; 24(3-4):227-38. PubMed ID: 17214599
[TBL] [Abstract][Full Text] [Related]
14. Effects of A(3) adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart.
Harrison GJ; Cerniway RJ; Peart J; Berr SS; Ashton K; Regan S; Paul Matherne G; Headrick JP
Cardiovasc Res; 2002 Jan; 53(1):147-55. PubMed ID: 11744023
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotection induced by adenosine A1 receptor agonists in a cardiac cell ischemia model involves cooperative activation of adenosine A2A and A2B receptors by endogenous adenosine.
Urmaliya VB; Church JE; Coupar IM; Rose'Meyer RB; Pouton CW; White PJ
J Cardiovasc Pharmacol; 2009 May; 53(5):424-33. PubMed ID: 19333129
[TBL] [Abstract][Full Text] [Related]
16. Species-dependent hemodynamic effects of adenosine A3-receptor agonists IB-MECA and Cl-IB-MECA.
Lasley RD; Narayan P; Jahania MS; Partin EL; Kraft KR; Mentzer RM
Am J Physiol; 1999 Jun; 276(6):H2076-84. PubMed ID: 10362690
[TBL] [Abstract][Full Text] [Related]
17. A3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure.
Lee HT; Ota-Setlik A; Xu H; D'Agati VD; Jacobson MA; Emala CW
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F267-73. PubMed ID: 12388399
[TBL] [Abstract][Full Text] [Related]
18. A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms.
Takano H; Bolli R; Black RG; Kodani E; Tang XL; Yang Z; Bhattacharya S; Auchampach JA
Circ Res; 2001 Mar; 88(5):520-8. PubMed ID: 11249876
[TBL] [Abstract][Full Text] [Related]
19. Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5'-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation.
Tracey WR; Magee W; Masamune H; Oleynek JJ; Hill RJ
Cardiovasc Res; 1998 Oct; 40(1):138-45. PubMed ID: 9876326
[TBL] [Abstract][Full Text] [Related]
20. Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.
Galal A; El-Bakly WM; Al Haleem EN; El-Demerdash E
Cancer Chemother Pharmacol; 2016 Feb; 77(2):309-22. PubMed ID: 26676227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
